A carregar...

Neoadjuvant therapy for gastrointestinal stromal tumor

Molecular-targeting therapy using tyrosine kinase inhibitor imatinib mesylate is effective for metastasis/recurrent gastrointestinal stromal tumors (GISTs). Likewise, imatinib would be effective in the neoadjuvant therapy for high-risk GIST. Neoadjuvant therapy may have the potential to increase the...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Transl Gastroenterol Hepatol
Main Authors: Ishikawa, Takashi, Kanda, Tatsuo, Kameyama, Hitoshi, Wakai, Toshifumi
Formato: Artigo
Idioma:Inglês
Publicado em: AME Publishing Company 2018
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5803029/
https://ncbi.nlm.nih.gov/pubmed/29441368
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/tgh.2018.01.01
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!